| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.98B | 2.72B | 2.60B | 2.32B | 2.01B |
| Gross Profit | 471.50M | 408.80M | 376.90M | 295.70M | 276.80M |
| EBITDA | 336.40M | 280.70M | 253.60M | 220.00M | 199.00M |
| Net Income | 158.30M | 134.30M | 113.10M | 111.40M | 103.50M |
Balance Sheet | |||||
| Total Assets | 1.74B | 1.53B | 1.38B | 1.26B | 1.14B |
| Cash, Cash Equivalents and Short-Term Investments | 12.50M | 5.90M | 27.00M | 20.40M | 200.00K |
| Total Debt | 257.00M | 178.30M | 126.50M | 121.70M | 106.20M |
| Total Liabilities | 648.40M | 543.30M | 472.50M | 421.50M | 373.60M |
| Stockholders Equity | 1.09B | 987.90M | 911.50M | 842.90M | 768.90M |
Cash Flow | |||||
| Free Cash Flow | 102.30M | 78.70M | 127.90M | 64.10M | 64.70M |
| Operating Cash Flow | 268.40M | 216.30M | 228.40M | 149.20M | 158.40M |
| Investing Cash Flow | -195.20M | -160.40M | -123.30M | -83.80M | -130.90M |
| Financing Cash Flow | -66.60M | -77.00M | -93.40M | -45.30M | -66.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £2.93B | 18.76 | 14.99% | 2.06% | 9.52% | 17.22% | |
74 Outperform | £1.73B | 7.84 | 15.61% | 1.62% | 2.31% | 9.04% | |
69 Neutral | £1.58B | 161.43 | 0.73% | 0.79% | 25.76% | -73.03% | |
68 Neutral | £13.37B | 14.27 | 8.44% | 2.98% | -2.16% | -24.87% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | £461.17M | 9.64 | 14.17% | 7.01% | 5.67% | 22.05% |